Zhen Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Zhen Li has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Jiansheng Lu
Laboratory of Advanced Biotechnology, Beijing Institute of Biotechnology, Beijing 100071, China
1 shared publication - Qing Xu
Institute of Life Sciences and Bio-Engineering, Beijing Jiaotong University, Beijing 100044, China
1 shared publication - Rong Wang
Laboratory of Advanced Biotechnology, Beijing Institute of Biotechnology, Beijing 100071, China
1 shared publication - Xiao Tan
Beijing Institute of Biotechnology, Beijing 100071, China
1 shared publication - Yun-Zhou Yu
Laboratory of Advanced Biotechnology, Beijing Institute of Biotechnology, Beijing 100071, China
1 shared publication - Zhixin Yang
Academy of Military Medical Sciences, Academy of Military Sciences, Beijing 100071, China
1 shared publication
Latest Publications
- Open Access
Functional EL-HN Fragment as a Potent Candidate Vaccine for the Prevention of Botulinum Neurotoxin Serotype E
Clostridium botulinum produces botulinum neurotoxin (BoNT), which is the most toxic known protein and the causative agent of human botulism. BoNTs have similar structures and functions, comprising three functional domains: catalytic domain (L), translocation domain (HN), and receptor-binding domain (Hc). In the present study, BoNT/E was selected as a model toxin to further explore the immunological significance of each domain. The EL-HN fragment (L and HN domains of BoNT/E) retained the enzymatic activity without in vivo neurotoxicity. Extensive investigations showed EL-HN functional fragment had the highest protective efficacy and contained some functional neutralizing epitopes. Further experiments demonstrated the EL-HN provided a superior protective effect compared with the EHc or EHc and EL-HN combination. Thus, the EL-HN played an important role in immune protection against BoNT/E and could provide an excellent platform for the design of botulinum vaccines and neutralizing antibodies. The EL-HN has the potential to replace EHc or toxoid as the optimal immunogen for the botulinum vaccine.
Open AccessFunctional EL-HN Fragment as a Potent Candidate Vaccine for the Prevention of Botulinum Neurotoxin Serotype E
Clostridium botulinum produces botulinum neurotoxin (BoNT), which is the most toxic known protein and the causative agent of human botulism. BoNTs have similar structures and functions, comprising three functional domains: catalytic domain (L), translocation domain (HN), and receptor-binding domain (Hc). In the present study, BoNT/E was selected as a model toxin to further explore the immunological significance of each domain. The EL-HN fragment (L and HN domains of BoNT/E) retained the enzymatic activity without in vivo neurotoxicity. Extensive investigations showed EL-HN functional fragment had the highest protective efficacy and contained some functional neutralizing epitopes. Further experiments demonstrated the EL-HN provided a superior protective effect compared with the EHc or EHc and EL-HN combination. Thus, the EL-HN played an important role in immune protection against BoNT/E and could provide an excellent platform for the design of botulinum vaccines and neutralizing antibodies. The EL-HN has the potential to replace EHc or toxoid as the optimal immunogen for the botulinum vaccine.